Retail & E-Commerce
🟢 SERP-Grounded (Light Telemetry)
Pague Menos
Programmatic AI Search & Model Visibility Audit
Share of Model (SOM)The percentage of time frontier AI models (ChatGPT, Claude, Gemini) recommend this brand for high-intent category queries.
30.0%
+1.2% 30-Day MomentumThe rolling 30-day change in algorithmic Share of Model. Positive momentum indicates increasing AI mindshare.
🧠 Neural Valency:VulnerableThe contextual sentiment of the AI's recommendation. 'Dominant' implies strong conviction, while 'Vulnerable' implies the model heavily conditions its recommendation.
Algorithmic Threat Detection
Primary Competitor Threat
Drogasil
Competitor Displacement Rate
35.0%
Competitors are displacing Pague Menos in 35.0% of high-intent buyer queries.The frequency at which AI models actively suggest a competitor as a superior alternative to this brand.
Algorithmic Rationale: Drogasil is aggressively capturing market share, likely due to wider product availability and competitive pricing on essential medications. Pague Menos may be losing customers seeking immediate or more affordable pharmacy options.
Missing AI Citations:High-authority domains (e.g., Reddit, G2) that models cite to justify recommending competitors, where this brand currently lacks presence.
[drogasil.com.br][ultrafarma.com.br][farmaciaprecodbaixo.com.br]⚠️ Identified Vulnerability:Price & Availability
Primary Threat Identified:Drogasil
Target Persona:Health-Conscious Consumers
🚨 Threat Velocity:6/10An algorithmic urgency score (1-10) indicating how rapidly competitors are capturing this brand's historical AI search share.
Unlock Full Threat Report (30 Free Credits)